Witryna1. What is Parallel distribution? Rev. June 2024. Centrally authorised medicinal products (“CAPs”) put on the market of one Member State can be marketed in any other Member State by a distributor, independently of the marketing-authorisation holder (“ parallel distribution ”). Parallel distribution (hereinafter also “PD”) pertains ... Witrynamac clinical research limited - mac clinical research finance ltd, monarch house, wakefield road, leeds, ls10 1dp, united kingdom
Application for new Manufacturer’s/Importer’s licence (MIA)
WitrynaThe MHRA products website allows you to find: The leaflets which are provided with medicines The description of the medicinal product’s properties and how it can be … WitrynaThe regulation and licensing of unlicensed CBPMs in the UK are undertaken by the Home Office, DHSC and the MHRA. This guidance is designed to provide information on supply, manufacture, importation and distribution of unlicensed CBPMs which have been specially manufactured or imported to the order of a Specialist doctor for the … lithomex repair
Sourcing medicines for the UK Market - GOV.UK
Witryna1.1 MHRA is responsible for ensuring that medicines and medical devices work, are safe and of an appropriate quality. MHRA’s primary aim is to safeguard public health through a system of regulation. Pharmaceutical manufacturers and distributors operating in the UK marketplace are subject to a system of licensing and inspection, which ensures that Witryna1 sty 2024 · MHRA aim to process all applications within 90 working days. If the human medicine you want to import contains a controlled substance (having or using it is controlled by law) you must contact the Home Office. Apply for a wholesaler licence You’ll need to apply for a wholesaler licence if you import medicine from: lithomex cesa